Zoomedia Blog
Blogs by: Barbara Lavery
Earlier this month Senator Edward Kennedy heard testimony from leading cancer advocates in a hearing titled Cancer: Challenges and Opportunities in the 21st Century. Greg Simon, President of FasterCures was one of the panel witnesses on May 8th and this week had the following to say on hearing the news of Senator Kennedy’s own diagnosis with a malignant brain tumor this week.
Tags: Oncology, Product Strategy, Patient Strategy
This week and next, my favorite shopping haunts in Soho are sharing space with Navigenics, the personalized DNA testing company. I usually visit SoHo for frocks at Legacy, cocktails at Thom Bar, and sushi at Blue Ribbon, but this week I can go to Soho and provide saliva in a cup to find out what my genes might tell me about the future of my health. Navigenics is renting space in a Soho storefront to promote its groundbreaking products.
Tags: Patient Strategy, Web 2.0
Last week, I attended the Epilepsy Pipeline Update conference, provided by our client the Epilepsy Therapy Project. The Epilepsy Therapy Project exists to overcome the barriers to successful translation of promising new research insights and to make new therapies a reality for patients...
Tags: Patient Strategy, Clinical Strategy, Epilepsy Therapy Project
Zoomedia recently had the privilege to spend a day with the Multiple Myeloma Research Foundation discussing challenges and strategies to help the organization advance its mission to fund research and bring patients to the center of the drug development process.
Tags: Patient Strategy, MMRF
Wait, hold onto your tux!! Now that the Oscars are over why not put your tux to better use at the ALF Salute to Excellence Awards Gala, the annual black tie event honoring those who have made an outstanding contribution to biotechnology and medical innovation. The event has been held annually for ten years and to date has raised more than $3 million dollars. The honorees this year include Hollings C. Renton, Chairman, President and Chief Executive Officer, Onyx Pharmaceuticals, Inc, Frank McCormick, PhD, FRS, Co-Founder of Onyx Pharmaceuticals, Inc., Samuel So, MD, FACS, Director, Asian Liver Center, Director, Liver Cancer Program, The Lui Hac Minh Professor of Surgery, Stanford University School of Medicine with special recognition going to Mark G. Edwards, Managing Director of Recombinant Capital, Inc.
Tags: Patient Strategy
